Roadzen director granted 152,732 stock options
Roadzen Inc. director Adhikari Saurav received a new stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Roadzen Inc. director Adhikari Saurav received a new stock option grant. On 09/15/2025, he was awarded stock options to purchase 152,732 ordinary shares at an exercise price of $2 per share. The options were acquired at a price of $0 and are exercisable starting 09/15/2025, with an expiration date of 09/15/2032. Following this grant, he beneficially owns 152,732 derivative securities directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 152,732 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Roadzen Inc. (RDZN) report for Adhikari Saurav?
How many Roadzen (RDZN) stock options were granted to the director?
What is the exercise price and term of the Roadzen (RDZN) options granted?
Did Adhikari Saurav pay anything to receive these Roadzen (RDZN) options?
How many Roadzen (RDZN) derivative securities does the director own after this transaction?
Is this Roadzen (RDZN) insider transaction a purchase or a sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.